Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1-2
|
| pubmed:dateCreated |
1981-7-20
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0361-5960
|
| pubmed:author |
pubmed-author:BianchiCC,
pubmed-author:BiraghiMM,
pubmed-author:CalzavaraM PMP,
pubmed-author:LibrettiAA,
pubmed-author:MarsoniSS,
pubmed-author:MorascaLL,
pubmed-author:PiazzeAA,
pubmed-author:RestelliGG,
pubmed-author:ScanniAA,
pubmed-author:ScapaticciRR,
pubmed-author:ScarpazzaGG,
pubmed-author:TomirottiMM
|
| pubmed:issnType |
Print
|
| pubmed:volume |
65
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
171-2
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading | |
| pubmed:articleTitle |
Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: a phase II study.
|
| pubmed:publicationType |
Letter
|